SCHEMBL5467503

SCHEMBL5467503

COc1ccc(C)cc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ccc(OCC(O)CO)cc3Cl)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.48
TP53 P04637 4/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
RAB9A P51151 1/20 0.48
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.47
RBP4 P02753 2/20 0.46
ALDH1A1 P00352 3/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
POLB P06746 1/20 0.43
HTR1A P08908 2/20 0.42
HTR1D P28221 2/20 0.42
HTR1B P28222 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456026 0.94 MAPT (0.48) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5460156 0.89 MAPT (0.51) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5459215 0.84 RBP4 (0.52) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5453431 0.83 RBP4 (0.54) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5459775 0.83 MAPT (0.51) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5467407 0.82 RBP4 (0.52) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5456806 0.82 RBP4 (0.55) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5462764 0.82 MAPT (0.52) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5462762 0.81 RBP4 (0.51) MAPTTP53MEN1KMT2ALMNA
SCHEMBL5465586 0.80 MAPT (0.47) MAPTTP53MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 MAPT 758/4885TP53 3723/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.